These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33900515)

  • 21. Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomised controlled trial.
    Borna S; Sahabi N
    Aust N Z J Obstet Gynaecol; 2008 Feb; 48(1):58-63. PubMed ID: 18275573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial: Assessment of perinatal outcome by use of tocolysis in early labor-APOSTEL IV trial.
    Nijman TA; van Vliet EO; Naaktgeboren CA; Oude Rengerink K; de Lange TS; Bax CJ; Bloemenkamp KW; van Eyck J; Kok M; Scheepers HC; Woiski M; Franx A; Mol BW; Oudijk MA
    Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():79-84. PubMed ID: 27567363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaginal progesterone combined with cervical pessary: A chance for pregnancies at risk for preterm birth?
    Stricker N; Timmesfeld N; Kyvernitakis I; Goerges J; Arabin B
    Am J Obstet Gynecol; 2016 Jun; 214(6):739.e1-739.e10. PubMed ID: 26692180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 17-alpha-hydroxyprogesterone caproate versus vaginal progesterone suppository for the prevention of preterm birth in women with a sonographically short cervix: A randomized controlled trial.
    Pirjani R; Heidari R; Rahimi-Foroushani A; Bayesh S; Esmailzadeh A
    J Obstet Gynaecol Res; 2017 Jan; 43(1):57-64. PubMed ID: 27775195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of maintenance tocolysis with nifedipine in established preterm labour on pregnancy prolongation and neonatal outcome.
    Aggarwal A; Bagga R; Girish B; Kalra J; Kumar P
    J Obstet Gynaecol; 2018 Feb; 38(2):177-184. PubMed ID: 28784001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical pessary to reduce preterm birth <34 weeks of gestation after an episode of preterm labor and a short cervix: a randomized controlled trial.
    Pratcorona L; Goya M; Merced C; Rodó C; Llurba E; Higueras T; Cabero L; Carreras E;
    Am J Obstet Gynecol; 2018 Jul; 219(1):99.e1-99.e16. PubMed ID: 29704487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaginal progesterone as maintenance treatment after an episode of preterm labour (PROMISE) study: a multicentre, double-blind, randomised, placebo-controlled trial.
    Palacio M; Cobo T; Antolín E; Ramirez M; Cabrera F; Mozo de Rosales F; Bartha JL; Juan M; Martí A; Oros D; Rodríguez À; Scazzocchio E; Olivares JM; Varea S; Ríos J; Gratacós E;
    BJOG; 2016 Nov; 123(12):1990-1999. PubMed ID: 27028759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data.
    Romero R; Conde-Agudelo A; El-Refaie W; Rode L; Brizot ML; Cetingoz E; Serra V; Da Fonseca E; Abdelhafez MS; Tabor A; Perales A; Hassan SS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):303-314. PubMed ID: 28067007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population differences and the effect of vaginal progesterone on preterm birth in women with threatened preterm labor (.).
    Hermans FJ; Karolinski A; Othenin-Girard V; Bertolino MV; Schuit E; Salgado P; Hösli I; Irion O; Laterra C; Mol BW; Martinez de Tejada B
    J Matern Fetal Neonatal Med; 2016 Oct; 29(19):3223-8. PubMed ID: 26586448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, double blinded, placebo controlled trial of oral dydrogesterone supplementation in the management of preterm labor.
    Areeruk W; Phupong V
    Sci Rep; 2016 Feb; 6():20638. PubMed ID: 26856618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue.
    Romero R; Sibai BM; Sanchez-Ramos L; Valenzuela GJ; Veille JC; Tabor B; Perry KG; Varner M; Goodwin TM; Lane R; Smith J; Shangold G; Creasy GW
    Am J Obstet Gynecol; 2000 May; 182(5):1173-83. PubMed ID: 10819855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intentional early delivery versus expectant management for preterm premature rupture of membranes at 28-32 weeks' gestation: A multicentre randomized controlled trial (MICADO STUDY).
    Pasquier JC; Claris O; Rabilloud M; Ecochard R; Picaud JC; Moret S; Buch D; Mellier G
    Eur J Obstet Gynecol Reprod Biol; 2019 Feb; 233():30-37. PubMed ID: 30553135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progesterone and nifedipine for maintenance tocolysis after arrested preterm labor: A systematic review and meta-analysis of randomized controlled trial.
    Ding MX; Luo X; Zhang XM; Bai B; Sun JX; Qi HB
    Taiwan J Obstet Gynecol; 2016 Jun; 55(3):399-404. PubMed ID: 27343323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study on the efficacy of nifedipine and indomethacin for prevention of preterm birth as monotherapy and combination therapy: a randomized clinical trial.
    Kashanian M; Shirvani S; Sheikhansari N; Javanmanesh F
    J Matern Fetal Neonatal Med; 2020 Oct; 33(19):3215-3220. PubMed ID: 30696306
    [No Abstract]   [Full Text] [Related]  

  • 35. Progesterone in women with arrested premature labor, a report of a randomised clinical trial and updated meta-analysis.
    Wood S; Rabi Y; Tang S; Brant R; Ross S
    BMC Pregnancy Childbirth; 2017 Aug; 17(1):258. PubMed ID: 28768474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [MEDICAL THERAPY FOR THE MANAGEMENT OF PRETERM LABOR: IS THERE A FIRST LINE AGENT?].
    Garmi G; Salim R
    Harefuah; 2015 Oct; 154(10):657-60, 674. PubMed ID: 26742230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.
    DeFranco EA; O'Brien JM; Adair CD; Lewis DF; Hall DR; Fusey S; Soma-Pillay P; Porter K; How H; Schakis R; Eller D; Trivedi Y; Vanburen G; Khandelwal M; Trofatter K; Vidyadhari D; Vijayaraghavan J; Weeks J; Dattel B; Newton E; Chazotte C; Valenzuela G; Calda P; Bsharat M; Creasy GW
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):697-705. PubMed ID: 17899571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevention of preterm birth with vaginal progesterone in women with preterm labor: which are the evidences?].
    Martinez de Tejada B; Othenin-Girard V; Irion O
    Rev Med Suisse; 2015 Oct; 11(492):2004, 2006-8, 2010. PubMed ID: 26672179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial.
    Norman JE; Marlow N; Messow CM; Shennan A; Bennett PR; Thornton S; Robson SC; McConnachie A; Petrou S; Sebire NJ; Lavender T; Whyte S; Norrie J;
    Lancet; 2016 May; 387(10033):2106-2116. PubMed ID: 26921136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment options and recommendations to reduce preterm births in women with short cervix.
    Slager J; Lynne S
    J Midwifery Womens Health; 2012 Jul; 57 Suppl 1():S12-8. PubMed ID: 22776244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.